130 related articles for article (PubMed ID: 24481768)
1. A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas.
Gao G; Kasperbauer JL; Tombers NM; Wang V; Mayer K; Smith DI
Genes Chromosomes Cancer; 2014 May; 53(5):392-401. PubMed ID: 24481768
[TBL] [Abstract][Full Text] [Related]
2. Common fragile sites, extremely large genes, neural development and cancer.
Smith DI; Zhu Y; McAvoy S; Kuhn R
Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
[TBL] [Abstract][Full Text] [Related]
3. DMD and IL1RAPL1: two large adjacent genes localized within a common fragile site (FRAXC) have reduced expression in cultured brain tumors.
McAvoy S; Ganapathiraju S; Perez DS; James CD; Smith DI
Cytogenet Genome Res; 2007; 119(3-4):196-203. PubMed ID: 18253029
[TBL] [Abstract][Full Text] [Related]
4. Common fragile sites (CFS) and extremely large CFS genes are targets for human papillomavirus integrations and chromosome rearrangements in oropharyngeal squamous cell carcinoma.
Gao G; Johnson SH; Vasmatzis G; Pauley CE; Tombers NM; Kasperbauer JL; Smith DI
Genes Chromosomes Cancer; 2017 Jan; 56(1):59-74. PubMed ID: 27636103
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of decreased expression of six large common fragile site genes in oropharyngeal squamous cell carcinomas.
Gao G; Kasperbauer JL; Tombers NM; Cornell MD; Smith DI
Transl Oncol; 2014 Dec; 7(6):726-31. PubMed ID: 25500082
[TBL] [Abstract][Full Text] [Related]
6. Differential loss of expression of common fragile site genes between oral tongue and oropharyngeal squamous cell carcinomas.
Soderberg C; Perez DS; Ukpo OC; Liang X; O'Reilly AG; Moore EJ; Kademani D; Smith DI
Cytogenet Genome Res; 2008; 121(3-4):201-10. PubMed ID: 18758160
[TBL] [Abstract][Full Text] [Related]
7. WWOX, large common fragile site genes, and cancer.
Gao G; Smith DI
Exp Biol Med (Maywood); 2015 Mar; 240(3):285-95. PubMed ID: 25595185
[TBL] [Abstract][Full Text] [Related]
8. Non-random inactivation of large common fragile site genes in different cancers.
McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
[TBL] [Abstract][Full Text] [Related]
9. Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Letessier A; Garrido-Urbani S; Ginestier C; Fournier G; Esterni B; Monville F; Adélaïde J; Geneix J; Xerri L; Dubreuil P; Viens P; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M; Chaffanet M
Oncogene; 2007 Jan; 26(2):298-307. PubMed ID: 16819513
[TBL] [Abstract][Full Text] [Related]
10. Disabled-1 is a large common fragile site gene, inactivated in multiple cancers.
McAvoy S; Zhu Y; Perez DS; James CD; Smith DI
Genes Chromosomes Cancer; 2008 Feb; 47(2):165-74. PubMed ID: 18008369
[TBL] [Abstract][Full Text] [Related]
11. Large common fragile site genes and cancer.
Smith DI; McAvoy S; Zhu Y; Perez DS
Semin Cancer Biol; 2007 Feb; 17(1):31-41. PubMed ID: 17140807
[TBL] [Abstract][Full Text] [Related]
12. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
[TBL] [Abstract][Full Text] [Related]
13. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
14. Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
Drusco A; Pekarsky Y; Costinean S; Antenucci A; Conti L; Volinia S; Aqeilan RI; Huebner K; Zanesi N
J Biomed Biotechnol; 2011; 2011():984505. PubMed ID: 21318118
[TBL] [Abstract][Full Text] [Related]
15. Very large common fragile site genes and their potential role in cancer development.
Gao G; Smith DI
Cell Mol Life Sci; 2014 Dec; 71(23):4601-15. PubMed ID: 25300511
[TBL] [Abstract][Full Text] [Related]
16. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
[TBL] [Abstract][Full Text] [Related]
17. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
19. Oncosuppressor proteins of fragile sites are reduced in cervical cancer.
Giarnieri E; Zanesi N; Bottoni A; Alderisio M; Lukic A; Vecchione A; Ziparo V; Croce CM; Mancini R
Cancer Lett; 2010 Mar; 289(1):40-5. PubMed ID: 19700237
[TBL] [Abstract][Full Text] [Related]
20. Loss of FHIT function in lung cancer and preinvasive bronchial lesions.
Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S
Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
